Inactive Instrument
Arix Bioscience plc Stock
Stocks
ARIX
GB00BD045071
Investment Management & Fund Operators
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Tom Davidson
DFI | Director of Finance/CFO | - | 01/05/2023 |
Laura Craig
IRC | Investor Relations Contact | - | - |
Jade Fletcher
AUD | Comptroller/Controller/Auditor | - | 10/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 29/04/2021 | |
| Director/Board Member | 63 | 10/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/05/23 | Free | Chief Executive Officer | 671,800 | 0.5200% | ||
| 04/05/23 | Sell | Chief Executive Officer | 22,238 | 0.0172% | ||
| 04/05/23 | Sell | Chief Executive Officer | 57,000 | 0.0441% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -1.05% | - | - | 235M | |
| -0.20% | -2.29% | +44.35% | +24.63% | 3.4B | |
| +1.01% | -2.08% | -11.20% | +3.86% | 3.13B | |
| +0.88% | -3.36% | +30.68% | +31.13% | 1.84B | |
| +1.21% | -0.15% | +78.80% | +205.61% | 1.4B | |
| 0.00% | 0.00% | -1.72% | -7.02% | 713M | |
| +2.95% | +0.85% | +124.31% | +269.89% | 697M | |
| +5.71% | +5.71% | -24.49% | -71.54% | 404M | |
| 0.00% | 0.00% | -3.97% | -7.05% | 401M | |
| 0.00% | 0.00% | -0.53% | -13.02% | 362M | |
| Average | +1.16% | +0.23% | +26.25% | +48.50% | 1.37B | |
| Weighted average by Cap. | +0.81% | -1.25% | +28.86% | +47.63% |
Employees
9
